Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Paul Lechat

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2019
Fluid therapy in the intraoperative settingJean-Paul Lechat, Philippe Van der Linden
Thrombosis Research|August 14, 2020
Impact of direct oral anticoagulant therapy on operative delay, blood loss, transfusion and postoperative morbidity mortality in hip fracture patient, an observational studyNicolas Gautier, Anne Pirson, Jean-Paul Lechat, et al.
Ecancermedicalscience|July 17, 2015
Biomarkers in immunonutrition programme, is there still a need for new ones? A brief reviewPatrice Forget, Garazi Echeverria, Simone Giglioli, et al.
Trials|November 28, 2021
The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trialZuzana Javorcikova, Michel Dangoisse, Stéphane Nikis, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 6, 2019
Fluid therapy in the intraoperative settingJean-Paul Lechat, Philippe Van der Linden
Thrombosis Research|August 14, 2020
Impact of direct oral anticoagulant therapy on operative delay, blood loss, transfusion and postoperative morbidity mortality in hip fracture patient, an observational studyNicolas Gautier, Anne Pirson, Jean-Paul Lechat, et al.
Ecancermedicalscience|July 17, 2015
Biomarkers in immunonutrition programme, is there still a need for new ones? A brief reviewPatrice Forget, Garazi Echeverria, Simone Giglioli, et al.
Trials|November 28, 2021
The place of S-ketamine in fibromyalgia treatment (ESKEFIB): study protocol for a prospective, single-center, double-blind, randomized, parallel-group, dose-escalation controlled trialZuzana Javorcikova, Michel Dangoisse, Stéphane Nikis, et al.
Pageof 1